NCT04982744 Registry of Li Fraumeni and Li Fraumeni Like Syndromes
| NCT ID | NCT04982744 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Ortopedico Rizzoli |
| Condition | Li-Fraumeni Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-07-02 |
| Primary Completion | 2030-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-07-02 with a primary completion date of 2030-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
ReLF is a retrospective and prospective registry, finalized for care and research purposes. It is articulated in main sections - strongly related and mutually dependent on each other - corresponding to different data domains: personal information, clinical data, genetic data, genealogical data, surgeries, etc. This approach has been developed to corroborate and integrate data from different resources and aspects of the diseases and to correlate genetic background and phenotypic outcomes, in order to better investigate diseases pathophysiology. Due to legal requirements, institutional directives and organizational issues, we are unable to include individuals residing outside Italy in the registry at this time. We are currently engaged in the preparation of a recruitment process for individuals residing outside Italy.
Eligibility Criteria
Inclusion Criteria: * All patients affected by Li Fraumeni or Li Fraumeni Like syndromes Exclusion Criteria: * Any condition unrelated to Li Fraumeni or Li Fraumeni Like syndromes
Contact & Investigator
Luca Sangiorgi, MSc
PRINCIPAL INVESTIGATOR
Istituto Ortopedico Rizzoli
Frequently Asked Questions
Who can join the NCT04982744 clinical trial?
This trial is open to participants of all sexes, studying Li-Fraumeni Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04982744 currently recruiting?
Yes, NCT04982744 is actively recruiting participants. Contact the research team at registri.malattierare@ior.it for enrollment information.
Where is the NCT04982744 trial being conducted?
This trial is being conducted at Bologna, Italy, Bologna, Italy.
Who is sponsoring the NCT04982744 clinical trial?
NCT04982744 is sponsored by Istituto Ortopedico Rizzoli. The principal investigator is Luca Sangiorgi, MSc at Istituto Ortopedico Rizzoli. The trial plans to enroll 200 participants.